Why I Sold Pfizer To Buy Novo Nordisk (NYSE:PFE)

Core Insights - The decision has been made to sell shares in Pfizer and use the proceeds to invest in Novo Nordisk, indicating a strategic shift in investment focus [1]. Group 1: Investment Strategy - The objective is to identify reasonably priced companies with steady long-term growth prospects and uncover small- and mid-cap companies with potential for exponential growth through fundamental analysis [1]. Group 2: Professional Background - The individual has a background as a corporate lawyer with an MBA and has spent 7 years practicing at prestigious law firms, now operating a boutique law firm focused on investment transactions and dispute resolution for the past 10 years [1].